Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omacor Plus Standard Therapies In Post MI Subjects Evaluation: The OPTIMISE Study

NCT01632878 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.

NCT NCT01632878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01632878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omacor Plus Standard Therapies In Post MI Subjects Evaluation: The OPTIMISE Study
Lead sponsor
Mylan Inc.
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2014
Enrollment
1,531 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction (mi)